Literature DB >> 28299426

Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands.

Lélia Batista de Souza1,2, Lucileide Castro de Oliveira3,4, Cassiano Francisco Weege Nonaka5, Maria Luiza Diniz de Sousa Lopes3, Leão Pereira Pinto3, Lélia Maria Guedes Queiroz3.   

Abstract

This study aimed to evaluate and compare the immunoexpression of glucose transporter-1 (GLUT-1) and angiogenic index between pleomorphic adenomas (PAs), adenoid cystic carcinomas (ACCs), and mucoepidermoid carcinomas (MECs) of the salivary glands, and establish associations with the respective subtype/histological grade. Twenty PAs, 20 ACCs, and 10 MECs were submitted to morphological and immunohistochemical analysis. GLUT-1 expression was semi-quantitatively evaluated and angiogenic index was assessed by microvessel counts using anti-CD34 antibody. Higher GLUT-1 immunoexpression was observed in the MECs compared to PAs and ACCs (p = 0.022). Mean number of microvessels was 66.5 in MECs, 40.4 in PAs, and 21.2 in ACCs (p < 0.001). GLUT-1 expression and angiogenic index showed no significant correlation in the tumors studied. Results suggest that differences in biological behavior of the studied tumors are related to GLUT-1. Benign and malignant salivary gland tumors differ in the angiogenic index; however, angiogenesis may be independent of the tumor cell's metabolic demand.

Entities:  

Keywords:  Adenoid cystic carcinoma; Angiogenic index; Glucose transporter; Mucoepidermoid carcinoma; Pleomorphic adenoma

Mesh:

Substances:

Year:  2017        PMID: 28299426     DOI: 10.1007/s00405-017-4530-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  40 in total

1.  CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.

Authors:  Jean-Philippe Dales; Stephane Garcia; Pascal Bonnier; Florence Duffaud; Lucile Andrac-Meyer; Olivier Ramuz; Marie-Noëlle Lavaut; Claude Allasia; Colette Charpin
Journal:  Am J Clin Pathol       Date:  2003-03       Impact factor: 2.493

2.  Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome.

Authors:  Jiali Zhang; Bin Peng; Xinming Chen
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

3.  Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation.

Authors:  Ana F Costa; Marcelo G Tasso; Fernanda V Mariano; Andresa B Soares; Carlos T Chone; Agricio N Crespo; Manuel F Fresno; Jose L Llorente; Carlos Suárez; Vera C de Araújo; Mario Hermsen; Albina Altemani
Journal:  Histopathology       Date:  2012-02-09       Impact factor: 5.087

4.  Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis.

Authors:  Tomoko Ota; Kazutoshi Ota; Hirofumi Jono; Hiromi Fujimori; Mitsuharu Ueda; Satoru Shinriki; Takanao Sueyoshi; Masanori Shinohara; Yukio Ando
Journal:  Oral Oncol       Date:  2010-07-15       Impact factor: 5.337

5.  Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior.

Authors:  Sergio V Cardoso; Kelen Christine N Souza; Paulo R Faria; Ana Lucia A Eisenberg; Fernando L Dias; Adriano M Loyola
Journal:  BMC Cancer       Date:  2009-11-04       Impact factor: 4.430

6.  Angiogenesis in salivary carcinomas with and without myoepithelial differentiation.

Authors:  A F Costa; A P D Demasi; V L L Bonfitto; J F L Bonfitto; C Furuse; V C Araújo; K Metze; A Altemani
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

7.  Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.

Authors:  Yonara Maria Freire Soares Marques; Marina de Deus Moura de Lima; Sérgio de Melo de Melo Alves; Fernando Augusto Soares; Vera Cavalcanti de Araújo; Décio dos Santos Pinto; Andrea Mantesso
Journal:  Oral Oncol       Date:  2008-05-15       Impact factor: 5.337

8.  Morphometric analysis of CD34-positive vessels in salivary gland adenoid cystic and mucoepidermoid carcinomas.

Authors:  H Luukkaa; J Laitakari; T Vahlberg; P Klemi; F Stenbäck; R Grénman
Journal:  J Oral Pathol Med       Date:  2009-08-06       Impact factor: 4.253

9.  Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.

Authors:  Yanislav Kolev; Hiroyuki Uetake; Satoru Iida; Toshiaki Ishikawa; Tatsuyuki Kawano; Kenichi Sugihara
Journal:  Ann Surg Oncol       Date:  2007-08-09       Impact factor: 5.344

10.  Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.

Authors:  Wei-Ming Wang; Zhi-Li Zhao; Wen-Feng Zhang; Yi-Fang Zhao; Lu Zhang; Zhi-Jun Sun
Journal:  Mol Med Rep       Date:  2015-05-22       Impact factor: 2.952

View more
  1 in total

Review 1.  Advances in the Treatment of Mucoepidermoid Carcinoma.

Authors:  Srikar Sama; Takefumi Komiya; Achuta Kumar Guddati
Journal:  World J Oncol       Date:  2021-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.